About us

Research and products:

Drug candidate mHAM 1102 is based on Primecell´s fifteen years experience with cell and tissue products, for example NTC Chondrograft®, which is in phase II/III clinical trial in EU, and extraordinary orthopedics outputs of University hospital Kralovske Vinohrady in Prague.

Cytokine Bioscience is a spin off Primecell´s research labs 4MEDi and NATIC, simillary as a spin off Biohealing (2018).

Primecell research of mHAM for orthopedics was granted by Technology agency of Czech republic, ID Trend1/FW01010339 in 2019.

Cytokine financing round A
https://cytokinebio.com/cytokine-financing-round-a/
Objev mladých brněnských vědců léčí chronické rány
https://www.novinky.cz/veda-skoly/clanek/objev-mladych-brnenskych-vedcu-leci-chronicke-rany-40063383

Leadership

Prof. Martin Krbec, MD, Ph.D.

Head of orthopedic clinic University hospital, Vice-chairman of Orthopedic society

Prof. Valér Džupa, MD

Vice dean School of medicine,
Charles University Prague

Serhiy Forostyak, MD, Ph.D.

Head of research

Mgr. Iveta Minaříková

Senior researcher

Eduard_Rodriguez_Perez

Eduard Rodriguez Perez, Ph.D.

Head of human amnion laboratories 4MEDi

Dipl.-Ing. Michal Zahradníček, MBA

Founder
Biomed enterpreneur venture,
4MEDI biotech accelerator